EP. 6: Dr Joshua Richter Explains Importance of Cytogenetics in Multiple Myeloma
February 1st 2022
Joshua Richter, MD, assistant professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, explains how the concept of cancer stage does not mean the same thing in multiple myeloma as it does in other cancers, why cytogenetics matter, and new data from trials involving quadruplet therapy.